Tag: Hepatitis D

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Hepatitis D

Eiger BioPharmaceuticals Announces Results from Multiple Presentations at the European ...

Added to Collection on: 2022-06-27 20:05:30

Tags for this article:

Medical specialties
Health care
Organic compounds
Hepatitis D
Antiviral drugs
Healthcare-associated infections
Breakthrough therapy
Interferon
Hepatitis
Peginterferon-alfa
Lonafarnib
HDV
eiger biopharmaceuticals inc
Lambda

Click the tags to see associated articles and topics

View Article Details
Hepatitis A cure? Scientists discover drug that stops virus replication, liver inflammation

Added to Collection on: 2022-07-04 19:10:56

Tags for this article:

Medical specialties
Clinical medicine
Health
Vaccine-preventable diseases
Infectious causes of cancer
Healthcare-associated infections
Zoonoses
Hepatitis
Virus
Antiviral drug
Hepatitis D
Viral hepatitis
Stanley M. Lemon

Click the tags to see associated articles and topics

View Article Details
Hepatitis B Virus Pipeline Assessment 2022 report covers Unmet Needs, Key Opportunities ...

Added to Collection on: 2022-07-23 05:57:10

Tags for this article:

Medical specialties
Clinical medicine
Health
Infectious causes of cancer
Vaccine-preventable diseases
Hepatitis
Arbutus Biopharma
Gilead Sciences
CccDNA
Viral hepatitis
Hepatitis D
Virus Key Companies
Hepatitis B virus

Click the tags to see associated articles and topics

View Article Details
Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q2 2022 Results - Seeking Alpha

Added to Collection on: 2022-08-07 01:04:36

Tags for this article:

Organic compounds
Chemical compounds
Branches of biology
Breakthrough therapy
Chloroarenes
Lonafarnib
Organobromides
Piperidines
Ureas
Hepatitis D
Peginterferon-alfa
Progeria
eiger biopharmaceuticals inc
Lambda
Maurice Raycroft
David Cory Thanks
Ingrid Choong
Sriram Ryali
Jefferies Robert Hazlett
United States
Colleen Craig
David Cory

Click the tags to see associated articles and topics

View Article Details
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR ... - ForexTV

Added to Collection on: 2022-11-06 17:23:29

Tags for this article:

Medical specialties
Medicine
Infectious diseases
RTT
Infectious causes of cancer
Antivirals
Hepatitis B
HBsAg
Hepatitis D
Viral hepatitis
Interferon
Hepatitis
Vir Biotechnology Inc.
Interferon Alpha

Click the tags to see associated articles and topics

View Article Details
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and ... - Yahoo Finance

Added to Collection on: 2022-11-06 16:02:46

Tags for this article:

Medical specialties
Viruses
Medicine
RTT
Infectious causes of cancer
Hepatitis B virus
Viral structural proteins
Antivirals
Hepatitis B
HBsAg
Hepatitis D
Viral hepatitis
Vir Biotechnology Inc.
Interferon Alpha

Click the tags to see associated articles and topics

View Article Details
Vir Biotech presents new data for functional cure of chronic Hep B virus - Labiotech

Added to Collection on: 2022-11-08 15:48:17

Tags for this article:

Medical specialties
Medicine
Infectious diseases
RTT
Antivirals
Infectious causes of cancer
Hepatitis B
HBsAg
Hepatitis D
Hepatitis
PEGylation
Pegylated interferon
Vir Biotech
Vir Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
Bluejay Therapeutics Received Regulatory Clearance to Initiate Clinical Studies of BJT-778 for

Added to Collection on: 2022-12-01 19:48:53

Tags for this article:

Medical specialties
Infectious diseases
Medicine
RTT
Infectious causes of cancer
Vaccine-preventable diseases
Antigens
HBsAg
Hepatitis B
Hepatitis D
Hepatitis
CHB

Click the tags to see associated articles and topics

View Article Details
Vir Biotechnology (VIR) Up on Positive Data From HDV Study - June 6, 2024 - Zacks.com

Added to Collection on: 2024-06-06 17:32:06

Tags for this article:

Hepatitis D
Peginterferon-alfa
Interferon
Vir Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2024 Earnings Call Transcript - Insider Monkey

Added to Collection on: 2024-11-02 14:33:27

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Pembrolizumab
Hepatitis D
Hepatitis
Sanofi
Biotechnology, Inc.
Vir Biotechnology Inc.
Richard Lepke
Mark Eisner
Marianne De Backer
Jason

Click the tags to see associated articles and topics

View Article Details